Global Multiple Myeloma Market to grow at a CAGR of 4.8% and reach $ Global Multiple Myeloma Market to grow at a CAGR o | Page 5

5.1.1.2 Alkylating agent 5.1.2 Targeted Therapy
5.1.2.1 Proteasome inhibitor
5.2 By Drug Type
5.2.1 Corticosteroids 5.2.1.1 Dexamethasone( Decadron) 5.2.1.2 Prednisone( Deltasone / Orasone)
5.2.2 Immunomodulatory agents 5.2.2.1 Thalidomide( Thalomid) 5.2.2.2 Lenalidomide( Revlimid) 5.2.2.3 Arsenic trioxide( Trisenox) 5.2.2.4 Plerixafor( Mozobil)
6. Geographical Analysis
6.1 North America 6.1.1 Introduction 6.1.2 United States 6.1.3 Canada
6.2 Europe 6.2.1 Introduction 6.2.2 U. K 6.2.3 Spain 6.2.4 Germany 6.2.5 Italy 6.2.6 France
6.3 Asia-Pacific 6.3.1 Introduction 6.3.2 China 6.3.3 India 6.3.4 Japan 6.3.5 South Korea 6.3.6 Australia
6.4 Latin America 6.4.1 Introduction